SCHEMBL6155785

SCHEMBL6155785

O=C(O)CC(CCO)CCCO

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CAMK2A Q9UQM7 1/20 0.40
GPR84 Q9NQS5 5/20 0.37
FFAR1 O14842 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
CACNA2D1 P54289 2/20 0.34
GSTK1 Q9Y2Q3 2/20 0.34
CACNB3 P54284 1/20 0.34
CACNA1C Q13936 1/20 0.34
PGR P06401 1/20 0.34
ADRA1A P35348 1/20 0.34
HTR2B P41595 1/20 0.34
CACNA2D2 Q9NY47 1/20 0.34
PTPN1 P18031 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
FOLH1 Q04609 1/20 0.33
GABRR1 P24046 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10478922 0.95 CAMK2A (0.43) CAMK2AGPR84FFAR1FFAR4SLC22A6
SCHEMBL28674069 0.91 GPR84 (0.42) CAMK2AGPR84FFAR1FFAR4SLC22A6
SCHEMBL692357 0.90 SLC22A6 (0.43) CAMK2AGPR84SLC22A6TDP1CACNA2D1
SCHEMBL1255952 0.88 BLM (0.40) CAMK2AGPR84FFAR1FFAR4CACNA2D1
SCHEMBL27857944 0.85 SLC22A6 (0.43) CAMK2AGPR84SLC22A6TDP1CACNA2D1
SCHEMBL28834415 0.85 GPR84 (0.47) GPR84FFAR1FFAR4SLC22A6TDP1
SCHEMBL3930995 0.85 GPR84 (0.47) GPR84FFAR1FFAR4TDP1ADRA1A
SCHEMBL373931 0.83 GPR84 (0.55) GPR84FFAR1FFAR4SLC22A6TDP1
SCHEMBL5203381 0.83 GPR84 (0.55) GPR84FFAR1FFAR4SLC22A6SMN1; SMN2
SCHEMBL9678244 0.82 ALDH1A1 (0.41) CAMK2AGPR84FFAR1FFAR4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499343-A4 A METHOD OF MODULATING CELLULAR ACTIVITY MEDVET SCIENCE PTY LTD (AU) 2005-12-28 EP disclosed
EP-1499343-A1 A METHOD OF MODULATING CELLULAR ACTIVITY MEDVET SCIENCE PTY. LTD. (AU) 2005-01-26 EP disclosed
WO-2003082322-A1 A METHOD OF MODULATING CELLULAR ACTIVITY MEDVET SCIENCE PTY. LTD. (AU) 2003-10-09 WO disclosed
US-6180779-B1 FROM A GLYCOCONJUGATE SUCH AS GLYCOPROTEIN BY REACTING A SALT-FREE AND ANHYDROUS GLYCOCONJUGATE WITH ANHYDROUS HYDRAZINE REAGENT UNDER CONTROLLED TIME AND TEMPERATURE TO RELEASE O-GLYCANS RECOVERABLE IN UNREDUCED, INTACT FORM OXFORD GLYCOSYSTEMS LIMITED (GB) 2001-01-30 US disclosed
EP-0462798-B1 Release and isolation of O-glycans OXFORD GLYCOSCIENCES UK LTD (GB) 1998-10-21 EP disclosed
EP-0462796-B1 Release and isolation of N-glycans and O-glycans OXFORD GLYCOSCIENCES UK LTD (GB) 1998-10-21 EP disclosed
US-5539090-A REACTION OF GLYCOCONJUGATES WITH HYDRAZINE TO RELEASE GLYCANS OXFORD GLYCOSYSTEMS LIMITED (GB) 1996-07-23 US disclosed
EP-0462796-A2 Release and isolation of N-glycans and O-glycans Oxford GlycoSystems Limited (GB) 1991-12-27 EP disclosed
EP-0462798-A2 Release and isolation of O-glycans Oxford GlycoSystems Limited (GB) 1991-12-27 EP disclosed
EP-0462797-A2 Release and isolation of N-glycans Oxford GlycoSystems Limited (GB) 1991-12-27 EP disclosed